Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
17-21 January, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
17-21 January, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Digital content

24 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/24/3193948/0/en/Onco360-Has-Been-Selected-as-The-National-Specialty-Pharmacy-Partner-for-HYRNUO-sevabertinib.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189595/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-Komzifti-ziftomenib.html

20 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/20/3169815/0/en/Onco360-Has-Been-Selected-as-a-Specialty-Pharmacy-Partner-for-PHYRAGO-dasatinib.html

16 Oct 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-10-16/cycle-pharmaceuticals-launches-its-first-oncology-product-phyrago-dasatinib-tablets-in-the-us

06 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/06/3161616/0/en/Onco360-Has-Been-Selected-as-a-Specialty-Pharmacy-Partner-for-INLURIYO-imlunestrant.html

08 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/08/3146482/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-Wayrilz-rilzabrutinib.html
ABOUT THIS PAGE